► Customized research for RKDA vs. VYGR!
► All in one page research, scroll down. Compare two other stocks.
► Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.
Done! Side by Side Research Below for RKDA vs. VYGR.
↗ Join Our Free Email Newsletter.
► ARCADIA BIOSCIENCES, INC. vs. Voyager Therapeutics
RKDA
Data Last Updated: 18 hours ago
↻ Update Column 1 to Most Recent
► Key Statistics
Cap: 48M
P/E: N/A
P/S: 32.88
Q P/B: 3.55
Y Rev: 1.46M
Q Rev: 392,000
Beta: -3.01

► Industry
Health Care/Life Sciences
RKDA Share Stats
► Outstanding Shares
6.27M
► Float Shares
7.01M
► Percent of Float Short
13.54%
RKDA Insider Stats
► Percent Outstanding Insider Ownership
2.18%
► Percent Outstanding Institution Ownership
14.63%
RKDA Social Stats
► Followers
0
► B/S Rating Today
0
► B/S Rating All-Time
N/A
Share RKDA Insights
RKDA Profile
► CEO
Mr. Kevin J. Comcowich
► Exchange
Nasdaq
► Employees
44.00
► About
Arcadia Biosciences, Inc. is an agricultural biotechnology company which engages in the development of agricultural products for the improvement of the environment and human health. It uses screening, breeding, and biotechnology techniques to create agricultural products...

RKDA Financials
Annual Financials
Income Statement
► Revenue
1.46M
► Net Income
(13.48M)
Cash Flow Statement
► Change in Cash / Investments
2.87M
Balance Sheet
► Cash / Investments
21.82M
► Short Term Debt
None
► Long Term Debt
None
► Total Current Assets
22.88M
► Total Current Liabilities
3.05M
► Total Assets
24.02M
► Total Liabilities
11.21M
► Stockholder Equity
12.82M
Quarterly Financials
Income Statement
► Q Revenue
392,000
► Q Net Income
(14.19M)
Cash Flow Statement
► Q Change in Cash / Investments
5.9M
Balance Sheet
► Q Cash / Investments
30.9M
► Q Short Term Debt
609,000
► Q Long Term Debt
113,000
► Q Total Current Assets
33.61M
► Q Total Current Liabilities
6.02M
► Q Total Assets
37.3M
► Q Total Liabilities
23.07M
► Q Stockholder Equity
13.54M

RKDA Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

VYGR
Data Last Updated: 20 hours ago
↻ Update Column 2 to Most Recent
► Key Statistics
Cap: 499M
P/E: N/A
P/S: 65.49
Q P/B: 4.61
Y Rev: 7.62M
Q Rev: 20.43M
Beta: 2.58

► Industry
257,713
VYGR Share Stats
► Outstanding Shares
36.83M
► Float Shares
23.37M
► Percent of Float Short
12.43%
VYGR Insider Stats
► Percent Outstanding Insider Ownership
3.83%
► Percent Outstanding Institution Ownership
98.24%
VYGR Social Stats
► Followers
1
► B/S Rating Today
0
► B/S Rating All-Time
+2
Share VYGR Insights
VYGR Profile
► CEO
Mr. G. Andre Turenne
► Exchange
Nasdaq
► Employees
123.00
► About
Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene theraphy programs include VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang...

VYGR Financials
Annual Financials
Income Statement
► Revenue
7.62M
► Net Income
(88.29M)
Cash Flow Statement
► Change in Cash / Investments
15.33M
Balance Sheet
► Cash / Investments
155.81M
► Short Term Debt
None
► Long Term Debt
None
► Total Current Assets
162.48M
► Total Current Liabilities
31.67M
► Total Assets
177.03M
► Total Liabilities
130.58M
► Stockholder Equity
46.45M
Quarterly Financials
Income Statement
► Q Revenue
20.43M
► Q Net Income
(15.01M)
Cash Flow Statement
► Q Change in Cash / Investments
2.76M
Balance Sheet
► Q Cash / Investments
307.4M
► Q Short Term Debt
3.02M
► Q Long Term Debt
None
► Q Total Current Assets
327.6M
► Q Total Current Liabilities
80.17M
► Q Total Assets
376.22M
► Q Total Liabilities
268.06M
► Q Stockholder Equity
108.16M

VYGR Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

